Active, Not Recruiting
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
NCT03319940
- Conditions
- Bites and Stings, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Yale New Haven Hospital New Haven, Connecticut, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Winship Cancer Institute Atlanta, Georgia, United States